Get started
RocketTickers

Regeneron Announces Encouraging Topline Phase 2 Data of High-dos

Long
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)  
RocketTickers  
NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
Beyond Technical Analysis
0
0
beyondta
REGN: Regeneron Pharmaceuticals, Inc.
2021-08-24 07:00:00
Regeneron Announces Encouraging Topline Phase 2 Data of High-dose aflibercept in Wet Age-related Macular Degeneration
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.